A study of the safety, tolerability and efficacy of self-administration of icatibant for acute attacks of hereditary angioedema

被引：0
|
作者：
Aberer, W. [1 ]
Wiednig, M. [1 ]
Reshef, A. [2 ]
Nair, N. [3 ]
Lachmann, A. [3 ]
Hoch, B. [3 ]
Bloom, B. [3 ]
Longhurst, H. [4 ]
Maurer, M. [5 ]
Kivity, S. [6 ]
Malbran, A. [7 ]
机构：
[1] Med Univ Graz, Graz, Austria
[2] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
[3] Shire Human Genet Therapies, Cambridge, MA USA
[4] Barts & London NHS Trust, London, England
[5] Charite, D-13353 Berlin, Germany
[6] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel
[7] Hosp Britan Buenos Aires, Buenos Aires, DF, Argentina
来源：
ALLERGY | 2011年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
166
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of icatibant self-administration for acute hereditary angioedema
    Boccon-Gibod, I.
    Bouillet, L.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 168 (03): : 303 - 307
  • [2] SAFETY, TOLERABILITY AND EFFICACY OF SELF-ADMINISTERED ICATIBANT FOR ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA
    Aberer, W.
    Toubi, E.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A112 - A112
  • [3] Self-administration of icatibant in acute attacks of Type I hereditary angioedema: A case report and review of hereditary angioedema
    Piras, Viviana
    Alves, Francisca
    Goncalo, Margarida
    DERMATOLOGIC THERAPY, 2019, 32 (06)
  • [4] Subcutaneous Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema: Comparison of Self-Administration to Administration at a Medical Facility
    Otani, Iris
    Lumry, William R.
    Li, Huamin Henry
    Chase, Chevy
    Craig, Timothy J.
    Riedl, Marc A.
    Zuraw, Bruce L.
    Banerji, Aleena
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB250 - AB250
  • [5] Self-administration of icatibant to treat hereditary angioedema in four patients with moderate to severe attacks
    Abajian, M.
    Doumoulakis, G.
    Agnieszka, M.
    Schoepke, N.
    Maurer, M.
    Magerl, M.
    ALLERGY, 2012, 67 : 353 - 353
  • [6] Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical Facility
    Otani, Iris M.
    Lumry, William R.
    Hurwitz, Shelley
    Li, Huamin Henry
    Craig, Timothy J.
    Holtzman, Niki S.
    Iandoli, Matthew I.
    Tucker, Julie
    Riedl, Marc A.
    Zuraw, Bruce L.
    Banerji, Aleena
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (02): : 442 - +
  • [7] Clinical experience with icatibant self-administration for patients with hereditary angioedema
    Boccon-Gibod, I
    Massot, C.
    Bouillet, L.
    ALLERGY, 2011, 66 : 425 - 426
  • [8] Safety and Convenience of Self-Administered Icatibant for the Treatment of Acute Hereditary Angioedema Attacks
    Aberer, Werner
    Bygum, Anette
    Nair, Nitin
    Kivity, Shmuel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB32 - AB32
  • [9] Benefits of Early Administration with Icatibant for the Treatment of Hereditary Angioedema Attacks
    Longhurst, Hilary
    Aberer, Werner
    Bouillet, Laurence
    Caballero, Teresa
    Fabien, Vincent
    Kanny, Gisele
    Zanichelli, Andrea
    Maurer, Marcus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB33 - AB33
  • [10] PATIENTS' OPINIONS OF SELF-ADMINISTERED ICATIBANT FOR THE TREATMENT OF ACUTE HEREDITARY ANGIOEDEMA ATTACKS
    Toubi, E.
    Aberer, W.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A112 - A113
12345